InvestorsHub Logo
Followers 2
Posts 193
Boards Moderated 0
Alias Born 03/26/2019

Re: microcapbiotech post# 28887

Wednesday, 11/06/2019 7:51:51 PM

Wednesday, November 06, 2019 7:51:51 PM

Post# of 34701
Sounds like they are still using the expensive genetic work that Marker is designed to avoid. Whatever may be the effectiveness and side effect profile they may achieve, if it's still basically genetically complex and expensive Car-T, they would be at a great cost disadvantage when marketed.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRKR News